RUNX2 and lung adenocarcinoma: In this study, we performed ChIP-seq analysis of samples of primary cultured cells from a patient with lung adenocarcinoma, and we demonstrated that the RUNX2 TF can bind to different genomic regions, such as intergenic regions, introns, and promoter regions.